Anti-Cancer Drugs

Journal Abbreviation: ANTI-CANCER DRUG
ISSN: 0959-4973
eISSN: 1473-5741
Publisher: Lippincott, Williams & Wilkins

Publications (4)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Biomarker-stratified first-line treatment of right-sided metastatic colon cancer with interdisciplinary collaboration in the IVOPAK II trial (2024) Vitali F, Merkel S, Schubart C, Schmid A, Eckstein M, Stöhr R, Kersting S, et al. Journal article Investigation of the cytotoxic activity of two novel digitoxigenin analogues on H460 lung cancer cells (2020) Boff L, Persich L, Brambila P, Ottoni FM, Munkert J, Ramos GS, Soares Viana AR, et al. Journal article Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors (2020) Grenader T, Pavel ME, Ruszniewski PB, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, et al. Journal article A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) (2019) Bischoff J, Barinoff J, Mundhenke C, Bauerschlag DO, Costa SD, Herr D, Luebbe K, et al. Journal article